Multiferon (interferon alpha) / SOBI 
Welcome,         Profile    Billing    Logout  
 16 Diseases   3 Trials   3 Trials   5 News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Multiferon (interferon alpha) / SOBI
2009-018146-38: Multicenter randomized controlled study comparing the efficacy and safety of natural Multi-subtype interferon alpha (Multiferon) in association with ribavirin versus retreatment with pegylated interferon-alpha 2a and ribavirin in non-responding genotype 1 hepatitis C patients.

Ongoing
3
110
Europe
Multiferon, Pegasys, Copegus, Multiferon, Pegasys, Copegus
Swedish Orphan International AB
Hepatitis C
 
 
2008-007104-28: Multiferon treatment of non-responders to peg-IFN alfa plus ribavirin standard of care treatment - a study of the early viral kinetics during the initial 12 weeks treatment.

Ongoing
2
20
Europe
Multiferon, Multiferon
Karolinska Universitetssjukhuset
HCV RNA response to a multivalent IFN (Multiferon 6 MU q.d. + ribavirin standard dosed) in prior non-responders to SOC (peg-IFN + ribavirin) during treatment the initial 12 weeks. Results of HCV RNA decline weeks 4 and 12 with SOC and this new treatment will be compared.
 
 
2011-005414-10: Nordic Study of Multiferon® in Early-Stage Primary Myelofibrosis - a Multicentre Pilot Study

Ongoing
2
20
Europe
Multiferon, Multiferon
The Nordic Myeloproliferative Neoplasm Group, Swedish Orphan Biovitrum
early and fibrotic stages of primary myelofibrosis
 
 

Download Options